About this trial

The study is designed to collect magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, CT images, and histopathology results to establish a database for early upper gastrointestinal cancer, precancerous lesions, and precancerous conditions.

Eligibility criteria

Qualifiers

Male or female participants aged ≥ 18 years

Patients with early upper gastrointestinal cancer referred for endoscopic submucosal dissection (ESD), or patients with upper gastrointestinal precancerous lesions or precancerous conditions referred for biopsy by esophagogastroduodenoscopy (EGD)

Participants who are willing and able to participate in this study, complete all required examinations and follow-up visits, and who have provided written informed consent

Disqualifiers

Patients who are not eligible for surgery or who refuse any abdominal surgery in case of capsule retention and endoscopic retrieval failure

Patients with cardiac pacemaker or other implanted electromedical devices which could interfere with magnetic resonance

Suspected or known intestinal stenosis or other known risk factors for capsule retention

Patients with dysphagia

Trial design

Treatments tested in this trial

  • magnetically-controlled capsule endoscopy, esophagogastroduodenoscopy, CT scan
  • ESD, biopsy

Treatment groups

No treatment groups listed

Locations

1
Changhai Hosptial200433, Shanghai China

Sponsors and collaborators

Changhai Hospital

Lead sponsor